Q2 2026 Holdings
Filed 2026-08-14 | 24 holdings | $1.2B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $379.4M | 6,897,652 | 31.2% |
| Alumis Inc(ALMS) | COM | 022307102 | $178.6M | 6,345,219 | 14.7% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $158.4M | 5,871,018 | 13.0% |
| Septerna Inc(SEPN) | COM | 81734D104 | $105.5M | 3,149,128 | 8.7% |
| Alamar Biosciences Inc(ALMR) | COMMON STOCK | 010911105 | $67.2M | 2,480,310 | 5.5% |
| Neurogene Inc(NGNE) | COM | 64135M105 | $54.0M | 1,717,127 | 4.4% |
| Kalaris Therapeutics Inc(KLRS) | COM | 482929106 | $52.4M | 12,881,175 | 4.3% |
| Spyglass Pharma Inc(SGP) | COM SHS | 85220G109 | $47.0M | 2,109,953 | 3.9% |
| Sutro Biopharma Inc(STRO) | COM SHS | 869367201 | $35.3M | 1,062,872 | 2.9% |
| Inventiva SA(IVA) | ADS | 46124U107 | $23.9M | 6,314,805 | 2.0% |
| Jade Biosciences Inc(JBIO) | COM NEW | 008064206 | $16.4M | 736,237 | 1.3% |
| Parabilis Medicines Inc(PBLS) | COM | 698955101 | $15.2M | 556,044 | 1.3% |
| VTV Therapeutics Inc(VTVT) | CL A NEW | 918385204 | $11.2M | 298,496 | 0.9% |
| Aquestive Therapeutics Inc(AQST) | COM | 03843E104 | $10.4M | 2,500,000 | 0.9% |
| Nkarta Inc(NKTX) | COM | 65487U108 | $9.9M | 3,507,666 | 0.8% |
| Artiva Biotherapeutics Inc(ARTV) | COM | 04317A107 | $9.3M | 954,861 | 0.8% |
| Rani Therapeutics Hldgs Inc(RANI) | COM CL A | 753018100 | $7.9M | 10,369,159 | 0.6% |
| Agomab Therapeutics NV(AGMB) | SPONSORED ADS | 00860C102 | $7.8M | 600,000 | 0.6% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $7.3M | 55,095 | 0.6% |
| X4 Pharmaceuticals Inc(XFOR) | COM NEW | 98420X202 | $6.5M | 1,395,587 | 0.5% |
| Eloxx Pharmaceuticals Inc(ELOX) | COM NEW | 29014R301 | $5.6M | 400,000 | 0.5% |
| Coherus Oncology Inc(CHRS) | COM | 19249H103 | $4.8M | 3,428,571 | 0.4% |
| Upstream BIO Inc(UPB) | COM | 91678A107 | $2.4M | 353,717 | 0.2% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $1.2M | 7,222,559 | 0.1% |